Showing results (1-10 of 500) with videos related to

Sort By:
Pageof 50
American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting|May 27, 2014
Risk stratification for wilms tumor: current approach and future directionsJeffrey S Dome, Elizabeth J Perlman, Norbert Graf
Current Opinion in Pediatrics|January 4, 2021
New approaches to risk stratification for Wilms tumorMarie V Nelson, Marry M van den Heuvel-Eibrink, Norbert Graf, et al.
Plos One|December 14, 2018
A unique subset of low-risk Wilms tumors is characterized by loss of function of TRIM28 (KAP1), a gene critical in early renal development: A Children's Oncology Group studyAmy E Armstrong, Samantha Gadd, Vicki Huff, et al.
International Journal of Radiation Oncology, Biology, Physics|June 5, 2012
Outcomes of patients with revised stage I clear cell sarcoma of kidney treated in National Wilms Tumor Studies 1-5John A Kalapurakal, Elizabeth J Perlman, Nita L Seibel, et al.
Cancer|August 29, 2013
Gain of 1q is associated with inferior event-free and overall survival in patients with favorable histology Wilms tumor: a report from the Children's Oncology GroupEric J Gratias, Lawrence J Jennings, James R Anderson, et al.
The Lancet. Oncology|January 1, 2004
Management of Wilms' tumour: current practice and future goalsJohn A Kalapurakal, Jeffrey S Dome, Elizabeth J Perlman, et al.
Pediatric Blood & Cancer|November 8, 2008
Anthropomorphic measurements and event-free survival in patients with favorable histology Wilms tumor: a report from the Children's Oncology GroupConrad V Fernandez, James Anderson, Norman E Breslow, et al.
Cancer Investigation|May 29, 2007
Telomere biology of pediatric cancerUri Tabori, Jeffrey S Dome
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 21, 2005
High telomerase RNA expression level is an adverse prognostic factor for favorable-histology Wilms' tumorJeffrey S Dome, Carol A Bockhold, Sierra M Li, et al.
Cancer|April 8, 2015
Characterization of adolescent and pediatric renal cell carcinoma: A report from the Children's Oncology Group study AREN03B2James I Geller, Peter F Ehrlich, Nicholas G Cost, et al.
Pageof 50